KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Titel:
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Auteur:
Brown, David M. Emanuelli, Andrés Bandello, Francesco Barranco, Jose Juan Escobar Figueira, João Souied, Eric Wolf, Sebastian Gupta, Vishali Ngah, Nor Fariza Liew, Gerald Tuli, Raman Tadayoni, Ramin Dhoot, Dilsher Wang, Lixin Bouillaud, Emmanuel Wang, Ying Kovacic, Lidija Guerard, Nicolas Garweg, Justus G.